Press Release – New York, NY – February 5, 2025 – Sichenzia Ross Ference Carmel LLP announced today that it represented BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX: BCT) , a clinical-stage …
Sichenzia Ross Ference Carmel LLP Represents A2Z Cust2Mate Solutions Corp. in $30 Million Public Offering and Concurrent Registered Direct Offering
Press Release – New York, NY – January 29, 2025 – Sichenzia Ross Ference Carmel LLP announced today that it represented A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) (FRA - WKN: A3CSQ), a global leader …
Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in $15 Million Public Offering of Li-Cycle
New York, NY - January 15, 2025 - Sichenzia Ross Ference Carmel LLP announced that it represented Aegis Capital Corp. in the $15 million public offering of Li-Cycle Holdings Corp. Aegis Capital Corp. …
Sichenzia Ross Ference Carmel LLP Represents HWH International Inc. in $1.76 Million Public Offering
Press Release – New York, NY – January 6, 2025 – Sichenzia Ross Ference Carmel LLP announced today that it represented HWH International Inc. (Nasdaq: HWH) in a public offering of 3,162,500 shares of …
Sichenzia Ross Ference Carmel LLP represents Alset Inc. in $1.5 Million Registered Direct Offering
Press Release – New York, NY – January 3, 2025 – Sichenzia Ross Ference Carmel LLP announced today that it represented Alset Inc. (NASDAQ: AEI), a diversified holding company principally engaged …
Sichenzia Ross Ference Carmel LLP Represents ThinkEquity in $5 Million Public Offering of CEL-SCI
New York, NY - December 30, 2024 - Sichenzia Ross Ference Carmel LLP announced that it represented ThinkEquity as the sole placement agent for the $5 million public offering of CEL-SCI …
